Jingyin Yan

Jingyin Yan is an Associate Professor in the Department of Medicine-Nephrology at Baylor College of Medicine. He serves as Medical Director of the Section of Nephrology at Baylor and the Medical Director of Davita ACE clinic. His research focuses on kidney stone disease management, home dialysis therapies, resistant hypertension, and acute/chronic kidney injury treatments. Dr. Yan is affiliated with the Baylor College of Medicine Medical Center in Houston, TX.

Education includes an MD from Shanghai Second Medical University, followed by residencies and fellowships at the University of Nevada School of Medicine and Baylor College of Medicine. His professional interests bridge clinical nephrology with translational research in fibrosis mechanisms and dialysis innovations.

Research interests emphasize renal fibrosis pathogenesis, bone marrow-derived fibroblast activation, and drug toxicity in kidney disease. Recent publications explore opioid-related fracture risks in hemodialysis patients and JAK/STAT signaling in fibrosis. He has led epidemiological studies comparing mortality outcomes in end-stage renal disease caused by kidney stones versus other etiologies.